Dual-sugar tests of small intestinal permeability are poor predictors of bacterial infections and mortality in cirrhosis: A prospective study

Table 1 Patients characteristics at baseline (n = 46) n (%)

	Median (range)/frequency
Age (yr)	59 (42-81)
Male sex	28 (61)
Etiology
Alcoholic liver disease	33 (72)
Viral hepatitis	6 (13)
Other	7 (15)
Comorbidity
Hepatocellular carcinoma	9 (20)
Diabetes	10 (22)
Child-Pugh stage
A	6 (13)
B	19 (41)
C	21 (46)
Ascites	31 (67)
Child-Pugh score	9 (5-14)
MELD score	15 (6-27)
Bilirubin (µmol/L)	61.4 (4-429)
International normalized ratio	1.4 (0.9-2.6)
Creatinine (µmol/L)	114 (43-533)
CrP (mg/L)	23.1 (2-112.4)
Albumin (g/L)	28 (17-51)
Sodium (mmol/L)	135 (125-144)
White blood cells (Gpt/L)	6.3 (1.2-22.2)
Platelets (Gpt/L)	135 (29-442)
Alanine aminotransferase (µmol/L*s)	1.41 (0.33-20.86)
Aspartate aminotransferase (µmol/L*s)	1.6 (0.4-8.8)
Medication
Non-selective beta blockers	19 (41)
Lactulose	21 (46)
Proton pump inhibitors	36 (78)
Terlipressin	1 (2)
Acetylsalicylic acid	5 (11)

Median and range or frequency and percent are shown.